• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

SyntheticMR

0.60 SEK

-3.56 %

Less than 1K followers

SYNT

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-3.56 %
-33.78 %
-35.64 %
-51.92 %
-50.82 %
-79.94 %
-97.36 %
-98.35 %
-71.11 %

SyntheticMR is a medical technology company that is active in the development of analysis and imaging methods. The technology is mainly used for magnetic resonance imaging (MRI) in healthcare. The technology is based on a quantification-based method that aims to increase the efficiency and quality of MRI examinations. The company was founded in 2007 and is headquartered in Linköping.

Read more
Market cap
53.24M SEK
Turnover
43.35K SEK
Revenue
57.05M
EBIT %
-86.45 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
25/8
2026

Interim report Q2'26

25/11
2026

Interim report Q3'26

16/2
2027

Annual report '26

Regulatory press release5/27/2026, 5:19 PM

Report from Annual General Meeting in SyntheticMR AB (publ)

SyntheticMR
Regulatory press release5/27/2026, 5:18 PM

Kommuniké från årsstämman i SyntheticMR AB (publ)

SyntheticMR
Regulatory press release5/12/2026, 6:12 AM

Interim report January - March 2026

SyntheticMR

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/12/2026, 6:11 AM

Delårsrapport januari - mars 2026

SyntheticMR
Regulatory press release4/21/2026, 6:02 AM

Notice to attend the Annual General Meeting of SyntheticMR AB (publ)

SyntheticMR
Regulatory press release4/21/2026, 6:01 AM

Kallelse till årsstämma i SyntheticMR AB (publ)

SyntheticMR
Regulatory press release4/9/2026, 6:01 AM

SyntheticMR AB: SyntheticMR publishes Annual Report for 2025

SyntheticMR
Regulatory press release4/9/2026, 6:00 AM

SyntheticMR AB: SyntheticMR publicerar årsredovisningen för 2025

SyntheticMR
Regulatory press release4/7/2026, 1:46 PM

Change of date for the Annual General Meeting in SyntheticMR AB (publ)

SyntheticMR
Regulatory press release4/7/2026, 1:44 PM

Ändrat datum för årsstämma i SyntheticMR AB (publ)

SyntheticMR
Regulatory press release2/11/2026, 3:51 PM

SyntheticMR AB: SyntheticMR's rights issue has been registered - conversion of BTA into shares

SyntheticMR
Regulatory press release2/11/2026, 3:50 PM

SyntheticMR AB: SyntheticMR:s företrädesemission är registrerad - omvandling av BTA till aktier

SyntheticMR
Regulatory press release2/6/2026, 7:30 AM

SyntheticMR AB: Year-End report January - December 2025

SyntheticMR
Regulatory press release2/6/2026, 7:29 AM

SyntheticMR AB: Bokslutskommuniké januari - december 2025

SyntheticMR
Regulatory press release2/4/2026, 2:16 PM

SyntheticMR AB: SyntheticMR publishes the outcome of the rights issue

SyntheticMR
Regulatory press release2/4/2026, 2:14 PM

SyntheticMR AB: SyntheticMR offentliggör utfall i företrädesemissionen

SyntheticMR
Press release1/20/2026, 6:19 AM

Today the subscription period commences in SyntheticMR AB's rights issue

SyntheticMR
Press release1/20/2026, 6:17 AM

Idag inleds teckningsperioden i SyntheticMR AB:s företrädesemission

SyntheticMR
Regulatory press release1/19/2026, 12:51 PM

SyntheticMR AB publishes information document regarding the rights issue

SyntheticMR
Regulatory press release1/19/2026, 12:50 PM

SyntheticMR AB offentliggör informationsdokument avseende företrädesemission

SyntheticMR